December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024 Bradley Lunde, Ph.D.Group Leader, Antibody Engineering at AdimabSpeaker
Profile
Bradley Lunde is a group leader in the Antibody Engineering department at Adimab LLC. He is one of several key contributors to the development of the yeast HCAb platform and the discovery and development of Adimab’s CD28 offering. He received his PhD from the University of Washington in 2009 and worked in Germany prior to joining Adimab in 2015.
Agenda Sessions
Development of a Versatile, Synthetic, Heavy Chain-only Antibody Platform in a Yeast-based Therapeutic Discovery Platform
, 5:45pmView Session